Abbott Laboratories, AbbVie, and Eli Lilly are top dividend stocks for income, growth, and value investors. Abbott has a 1.8% yield and a 53-year streak of dividend increases. AbbVie boasts a 3% yield, strong earnings growth, and low valuation. Eli Lilly dominates the weight loss market and offers promising pipeline programs.

Abbott Laboratories, AbbVie, and Eli Lilly are recommended by Motley Fool contributors for September. Abbott offers stability and consistency, AbbVie has impressive dividend increases, and Eli Lilly dominates the weight loss market with exciting pipeline prospects. All three stocks cater to different investor preferences.

Read more at Yahoo Finance: 3 No-Brainer Dividend Stocks to Buy in September